Correction: Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance

Affiliations

• ¹ Department of Hepatobiliary Surgery, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China.
• ² Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, China.
• ³ Department of Clinical Laboratory, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China.
• ⁴ Department of Clinical Laboratory, The Third Xiangya Hospital of Central South University, Hunan, China.
• ⁵ Department of Oncology, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China. gxnnsyq@163.com.
• ⁶ Department of Clinical Laboratory, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China. sunyifan@gxmu.edu.cn.